Oligonucleotide Synthesis Market By Product Type, By Application, By End User - Global Industry Analysis and Forecast to 2025

Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101345

Oligonucleotide Synthesis Market By Product Type (Equipment, Reagents & Consumables and Synthesized oligonucleotides) By Application (Diagnostics, Research, Therapeutics) By End User (Research Institutes, Biotechnology & Pharmaceutical Companies and Diagnostic Laboratories) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Oligonucleotide Synthesis Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Oligonucleotides are short sections of nucleic acids that are combined utilizing enzyme chemistry and genetic engineering. These are for the most part utilized in labs in applications, for example, diagnostics, therapeutic and in addition industrial and academic. These are made use of from initial screening and research through to target approval and production of medication. Oligonucleotides synthesis takes place either industrially to give services to different end users or independently by means of DNA synthesizers for self-utilization. These days, major upgrades in oligonucleotide synthesis, automation and amplification has totally transformed biological research. It is likewise conceivable to do the customizations and get the required succession online effortlessly and at the required time.

Market Segmentation

The Oligonucleotide Synthesis Market is segmented by product type into equipment, reagents & consumables and synthesized oligonucleotides; by application into diagnostics, research and therapeutics; by end user research institutes, biotechnology & pharmaceutical companies and diagnostic laboratories.

Oligonucleotide Synthesis Market By Product Type

  • Equipment
  • Reagents & Consumables
  • Synthesized oligonucleotides

Oligonucleotide Synthesis Market By Application

  • Diagnostics
  • Research
    • Quantitative polymerase chain reaction (qPCR)
    • Gene synthesis
    • Polymerase chain reaction (PCR)
    • Sequencing
    • Others
  • Therapeutics
    • Deoxyribonucleic acid (DNA)/antisense oligonucleotides
    • Ribonucleic acid interface (RNAi)
    • Immunotherapy applications
    • Nucleic acid aptamers

Oligonucleotide Synthesis Market By End User

  • Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Diagnostic Laboratories

 

Regional Insights

On a global front, the Oligonucleotide Synthesis Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North America contributed for the biggest market share in the worldwide oligonucleotide synthesis market inferable from rising interest in R&D. Likewise, the developing pharmaceutical and biotechnology enterprises in this district are additionally foreseen to add to the boost market development in the upcoming years.

  • Oligonucleotide Synthesis Market, By Region
    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Thermo Fisher Scientific, Biosearch Technologies, GE Healthcare, Sigma-Aldrich, Eurogentec, Integrated DNA Technologies, Eurofins Clinical Genetics India Pvt. Ltd, GeneDesign Inc, Bioautomation Corporation and TriLink BioTechnologies Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Thermo Fisher Scientific
  • Biosearch Technologies
  • GE Healthcare
  • Sigma-Aldrich
  • Eurogentec
  • Integrated DNA Technologies
  • Eurofins Clinical Genetics India Pvt. Ltd
  • GeneDesign Inc
  • Bioautomation Corporation
  • TriLink BioTechnologies Inc

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?

Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Oligonucleotide Synthesis Market, By Product Type, Estimates and Forecast, 2014-2025($Billion)

o    Equipment

o    Reagents & Consumables

o    Synthesized oligonucleotides

·         Oligonucleotide Synthesis Market, By Application, Estimates and Forecast, 2014-2025($Billion)

o    Diagnostics

o    Research

§  Quantitative polymerase chain reaction (qPCR)

§  Gene synthesis

§  Polymerase chain reaction (PCR)

§  Sequencing

§  Others

o    Therapeutics

§  Deoxyribonucleic acid (DNA)/antisense oligonucleotides

§  Ribonucleic acid interface (RNAi)

§  Immunotherapy applications

§  Nucleic acid aptamers

·         Oligonucleotide Synthesis Market, By End User, Estimates and Forecast, 2014-2025($Billion)

o    Research Institutes

o    Biotechnology & Pharmaceutical Companies

o    Diagnostic Laboratories

·         Oligonucleotide Synthesis Market, By Region, Estimates and Forecast, 2014-2025($Billion)

o    North America

§  North America Oligonucleotide Synthesis Market, By Country

o    U.S. Oligonucleotide Synthesis Market

o    Canada Oligonucleotide Synthesis Market

o    Mexico Oligonucleotide Synthesis Market

o    Europe

§  Europe Oligonucleotide Synthesis Market, By Country

o    Germany Oligonucleotide Synthesis Market

o    UK Oligonucleotide Synthesis Market

o    France Oligonucleotide Synthesis Market

o    Russia Oligonucleotide Synthesis Market

o    Italy Oligonucleotide Synthesis Market

o    Rest of Europe Oligonucleotide Synthesis Market

o    Asia-Pacific

§  Asia-Pacific Oligonucleotide Synthesis Market, By Country

o    China Oligonucleotide Synthesis Market

o    Japan Oligonucleotide Synthesis Market

o    South Korea Oligonucleotide Synthesis Market

o    India Oligonucleotide Synthesis Market

o    Southeast Asia Oligonucleotide Synthesis Market

o    Rest of Asia-Pacific Oligonucleotide Synthesis Market

o    South America

§  South America Oligonucleotide Synthesis Market

o    Brazil Oligonucleotide Synthesis Market

o    Argentina Oligonucleotide Synthesis Market

o    Columbia Oligonucleotide Synthesis Market

o    Rest of South America Oligonucleotide Synthesis Market

o    Middle East and Africa

§  Middle East and Africa Oligonucleotide Synthesis Market

o    Saudi Arabia Oligonucleotide Synthesis Market

o    UAE Oligonucleotide Synthesis Market

o    Egypt Oligonucleotide Synthesis Market

o    Nigeria Oligonucleotide Synthesis Market

o    South Africa Oligonucleotide Synthesis Market

o    Rest of MEA Oligonucleotide Synthesis Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Oligonucleotide Synthesis  Market, By Product Type

5.1.     Introduction

5.2.     Global Oligonucleotide Synthesis  Revenue and Market Share by Product Type (2014-2018)

5.2.1.  Global Oligonucleotide Synthesis  Revenue and Revenue Share by Product Type (2014-2018)

5.3.     Equipment

5.3.1.  Global Equipment Revenue and Growth Rate (2014-2018)

5.4.     Reagents & Consumables

5.4.1.  Global Reagents & Consumables Revenue and Growth Rate (2014-2018)

5.5.     Synthesized oligonucleotides

5.5.1.  Global Synthesized oligonucleotides Revenue and Growth Rate (2014-2018)

6.       Oligonucleotide Synthesis  Market, By Application

6.1.     Introduction

6.2.     Global Oligonucleotide Synthesis  Revenue and Market Share by Application (2014-2018)

6.2.1.  Global Oligonucleotide Synthesis  Revenue and Revenue Share by Application (2014-2018)

6.3.     Diagnostics

6.3.1.  Global Diagnostics Revenue and Growth Rate (2014-2018)

6.4.     Research

6.4.1.  Global Research Revenue and Growth Rate (2014-2018)

6.4.2.  Global Research By Types

6.4.3.  Quantitative polymerase chain reaction (qPCR)

6.4.3.1.  Global Quantitative polymerase chain reaction (qPCR) Revenue and Growth Rate (2014-2018)

6.4.4.  Gene synthesis

6.4.4.1.  Global Gene synthesis Revenue and Growth Rate (2014-2018)

6.4.5.  Polymerase chain reaction (PCR)

6.4.5.1.  Global Polymerase chain reaction (PCR) Revenue and Growth Rate (2014-2018)

6.4.6.  Sequencing

6.4.6.1.  Global Sequencing Revenue and Growth Rate (2014-2018)

6.4.7.  Others

6.4.7.1.  Global Others Revenue and Growth Rate (2014-2018)

6.5.     Therapeutics

6.5.1.  Global Therapeutics Revenue and Growth Rate (2014-2018)

6.5.2.  Global Therapeutics By Types

6.5.3.  Deoxyribonucleic acid (DNA)/antisense oligonucleotides

6.5.3.1.  Global Ribonucleic acid interface (RNAi) Revenue and Growth Rate (2014-2018)

6.5.4.  Ribonucleic acid interface (RNAi)

6.5.4.1.  Global Ribonucleic acid interface (RNAi) Revenue and Growth Rate (2014-2018)

6.5.5.  Immunotherapy applications

6.5.5.1.  Global Immunotherapy applications Revenue and Growth Rate (2014-2018)

6.5.6.  Nucleic acid aptamers

6.5.6.1.  Global Nucleic acid aptamers Revenue and Growth Rate (2014-2018)

7.       Oligonucleotide Synthesis  Market, By End-users

7.1.     Introduction

7.2.     Global Oligonucleotide Synthesis  Revenue and Market Share by End-users (2014-2018)

7.2.1.  Global Oligonucleotide Synthesis  Revenue and Revenue Share by End-users (2014-2018)

7.3.     Research Institutes

7.3.1.  Global Research Institutes Revenue and Growth Rate (2014-2018)

7.4.     Biotechnology & Pharmaceutical Companies

7.4.1.  Global Biotechnology & Pharmaceutical Companies Revenue and Growth Rate (2014-2018)

7.5.     Diagnostic Laboratories

7.5.1.  Global Diagnostic Laboratories Revenue and Growth Rate (2014-2018)

8.       Oligonucleotide Synthesis  Market, By Region

8.1.     Introduction

8.2.     Global Oligonucleotide Synthesis  Revenue and Market Share by Regions

8.2.1.  Global Oligonucleotide Synthesis  Revenue by Regions (2014-2018)

8.3.     North America Oligonucleotide Synthesis  by Countries

8.3.1.  North America Oligonucleotide Synthesis  Revenue and Growth Rate (2014-2018)

8.3.2.  North America Oligonucleotide Synthesis  Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Oligonucleotide Synthesis  by Countries

8.4.1.  Europe Oligonucleotide Synthesis  Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Oligonucleotide Synthesis  Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Oligonucleotide Synthesis  by Countries

8.5.1.  Asia-Pacific Oligonucleotide Synthesis  Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Oligonucleotide Synthesis  Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Oligonucleotide Synthesis  by Countries

8.6.1.  South America Oligonucleotide Synthesis  Revenue and Growth Rate (2014-2018)

8.6.2.  South America Oligonucleotide Synthesis  Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Oligonucleotide Synthesis  by Countries

8.7.1.  Middle East and Africa Oligonucleotide Synthesis  Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Oligonucleotide Synthesis  Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Thermo Fisher Scientific

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Biosearch Technologies

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     GE Healthcare

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Sigma-Aldrich

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Eurogentec

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Integrated DNA Technologies

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Eurofins Clinical Genetics India Pvt. Ltd

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     GeneDesign Inc

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Bioautomation Corporation

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

9.10. TriLink BioTechnologies Inc

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.       Revenue and Market Share

10.    Global Oligonucleotide Synthesis  Market Competition, by Manufacturer

10.1. Global Oligonucleotide Synthesis  Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Oligonucleotide Synthesis  Price By Region (2016-2017)

10.3. Top 5 Oligonucleotide Synthesis  Manufacturer Market Share

10.4. Market Competition Trend

11.    Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.1. Global Oligonucleotide Synthesis  Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Oligonucleotide Synthesis  Market Forecast by Regions (2018-2025)

11.2.1.      North America Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.1.1. United States Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.1.2. Canada Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.1.3. Mexico Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.2.      Europe Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.2.1. Germany Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.2.2. France Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.2.3. UK Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.2.4. Russia Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.2.5. Italy Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.3.      Asia-Pacific Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.3.1. China Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.3.2. Japan Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.3.3. Korea Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.3.4. India Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.4.      South America Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.4.1. Brazil Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.4.2. Argentina Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.4.3. Columbia Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.4.4. Rest of South America Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.      Middle East and Africa Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.3. Egypt Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.4. Nigeria Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.5. South Africa Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.6. Turkey Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Oligonucleotide Synthesis  Market Forecast (2018-2025)

11.3. Oligonucleotide Synthesis  Market Forecast by Product Type (2018-2025)

11.3.1.      Oligonucleotide Synthesis  Forecast by Product Type (2018-2025)

11.3.2.      Oligonucleotide Synthesis  Market Share Forecast by Product Type (2018-2025)

11.4. Oligonucleotide Synthesis  Market Forecast by Application (2018-2025)

11.4.1.      Oligonucleotide Synthesis  Forecast by Application (2018-2025)

11.4.2.      Oligonucleotide Synthesis  Market Share Forecast by Application (2018-2025)

11.5. Oligonucleotide Synthesis  Market Forecast by End-users (2018-2025)

11.5.1.      Oligonucleotide Synthesis  Forecast by End-users (2018-2025)

11.5.2.      Oligonucleotide Synthesis  Market Share Forecast by End-users (2018-2025)


List of Tables

List of Tables and Figures
Figure United States Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Oligonucleotide Synthesis Revenue and Revenue Share by Product Type (2014-2018)
Figure Global Equipment Revenue and Growth Rate (2014-2018)
Figure Global Reagents & Consumables Revenue and Growth Rate (2014-2018)
Figure Global Synthesized oligonucleotides Revenue and Growth Rate (2014-2018)
Table Global Oligonucleotide Synthesis Revenue and Revenue Share by Application (2014-2018)
Figure Global Diagnostics Revenue and Growth Rate (2014-2018)
Figure Global Research Revenue and Growth Rate (2014-2018)
Figure Global Therapeutics Revenue and Growth Rate (2014-2018)
Table Global Oligonucleotide Synthesis Revenue and Revenue Share by End-users (2014-2018)
Figure Global Research Institutes Revenue and Growth Rate (2014-2018)
Figure Global Biotechnology & Pharmaceutical Companies Revenue and Growth Rate (2014-2018)
Figure Global Diagnostic Laboratories Revenue and Growth Rate (2014-2018)
Table Global Oligonucleotide Synthesis Revenue by Regions (2014-2018)
Figure North America Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure North America Oligonucleotide Synthesis Revenue and Growth Rate (2014-2018)
Figure North America Oligonucleotide Synthesis by Countries (2014-2018)
Figure North America Oligonucleotide Synthesis Revenue (Million USD) by Countries (2014-2018)
Figure United States Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure United States Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Canada Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Mexico Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Europe Oligonucleotide Synthesis Revenue and Growth Rate (2014-2018)
Figure Europe Oligonucleotide Synthesis by Countries (2014-2018)
Figure Europe Oligonucleotide Synthesis Revenue (Million USD) by Countries (2014-2018)
Figure Germany Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Germany Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure France Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure UK Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Russia Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Italy Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Rest of Europe Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Asia-Pacific Oligonucleotide Synthesis Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Oligonucleotide Synthesis by Countries (2014-2018)
Figure Asia-Pacific Oligonucleotide Synthesis Revenue (Million USD) by Countries (2014-2018)
Figure China Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure China Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Japan Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Korea Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure India Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Southeast Asia Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure South America Oligonucleotide Synthesis Revenue and Growth Rate (2014-2018)
Figure South America Oligonucleotide Synthesis by Countries (2014-2018)
Figure South America Oligonucleotide Synthesis Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Brazil Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Argentina Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Columbia Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Rest of South America Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Middle East and Africa Oligonucleotide Synthesis Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Oligonucleotide Synthesis by Countries (2014-2018)
Figure Middle East and Africa Oligonucleotide Synthesis Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Saudi Arabia Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure United Arab Emirates Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Egypt Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Nigeria Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure South Africa Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Turkey Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Oligonucleotide Synthesis Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2014-2018)
Table Thermo Fisher Scientific Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biosearch Technologies Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sigma-Aldrich Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eurogentec Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Integrated DNA Technologies Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eurofins Clinical Genetics India Pvt. Ltd Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GeneDesign Inc Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bioautomation Corporation Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Table TriLink BioTechnologies Inc Oligonucleotide Synthesis Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Oligonucleotide Synthesis Market Share by Manufacturer
Figure Global Oligonucleotide Synthesis Revenue and Market Share by Manufacturer
Table Global Oligonucleotide Synthesis Price by Region (2016-2017)
Figure Top 5 Oligonucleotide Synthesis Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Oligonucleotide Synthesis Revenue (Millions USD) and Growth Rate (2018-2025)
Table Oligonucleotide Synthesis Market Forecast by Regions (2018-2025)
Figure North America Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure United States Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Canada Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Mexico Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Europe Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Germany Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure France Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure UK Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Russia Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Italy Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Rest of Europe Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Asia-Pacific Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure China Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Japan Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Korea Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure India Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Southeast Asia Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure South America Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Brazil Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Argentina Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Columbia Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Rest of South America Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Middle East and Africa Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Saudi Arabia Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure United Arab Emirates Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Egypt Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Nigeria Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure South Africa Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Turkey Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Oligonucleotide Synthesis Market Forecast (2018-2025)
Figure Global Oligonucleotide Synthesis Forecast by Product Type (2018-2025)
Figure Global Oligonucleotide Synthesis Market Share Forecast by Product Type (2018-2025)
Figure Global Oligonucleotide Synthesis Forecast by Product Type (2018-2025)
Figure Global Oligonucleotide Synthesis Forecast by Application (2018-2025)
Figure Global Oligonucleotide Synthesis Market Share Forecast by Application (2018-2025)
Figure Global Oligonucleotide Synthesis Forecast by Application (2018-2025)
Figure Global Oligonucleotide Synthesis Forecast by End-users (2018-2025)
Figure Global Oligonucleotide Synthesis Market Share Forecast by End-users (2018-2025)
Figure Global Oligonucleotide Synthesis Forecast by End-users (2018-2025)


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*